Large anti-HER2/<i>neu</i>liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer

Abstract

The findings of this study suggest that large targeted liposomes administered i.p. could be a potent drug-delivery strategy for locoregional therapy of i.p. micrometastatic tumors.